Bob Warnock is an experienced biostatistics professional currently serving as the Sr. Director of Biostatistics at Emergent BioSolutions since April 2023, where leadership is provided for clinical and non-clinical biostatistics functions related to vaccines and medical countermeasures. Previous positions include Sr. Director of Biometrics at Certara, Statistical Science Director at AstraZeneca, and Principal Consultant at IQVIA. Warnock has held significant roles at UCB, Genzyme, GlaxoSmithKline, Insmed, Intrabiotics Pharmaceuticals, and SCIREX Corporation, with responsibilities spanning statistical management, clinical development, and observational data analysis across various therapeutic areas. Educational qualifications include an MS in Statistics from California State University - East Bay and a BS in Economics from Santa Clara University.
This person is not in any teams
This person is not in any offices